Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Humaid O Al-Shamsi

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Ecancermedicalscience|April 23, 2021
National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemicZineb Benbrahim, Layth Mula-Hussain, Humaid O Al-Shamsi, et al.
Therapeutic Advances in Medical Oncology|September 4, 2024
Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trialsSara A Almansour, Mohammad A Y Alqudah, Ziad Abuhelwa, et al.
Cancer Treatment and Research Communications|February 27, 2022
Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer ConsortiumAhmed Allehebi, Khaled Al Kattan, Mashael Al Rujaib, et al.
Blood Advances|April 23, 2025
Statin use and survival in SLL/CLL treated with ibrutinib: Pooled analysis of four randomized controlled trialsAhmad Y Abuhelwa, Sara A Almansour, Jennifer R Brown, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experienceHumaid O Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Molecular spectrum of <i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i>, <i>PIK3CA</i>, <i>TP53</i>, and <i>APC</i> somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution patternHumaid O Al-Shamsi, Jeremy Jones, Yazan Fahmawi, et al.
European Journal of Haematology|March 14, 2025
Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple MyelomaAhmad Y Abuhelwa, Sara A Almansour, Ethan Basch, et al.
The Oncologist|June 15, 2020
Evolution of Cancer Care in Response to the COVID-19 PandemicEric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
The Oncologist|May 8, 2020
In ReplyEric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
JCO Precision Oncology|February 9, 2022
Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical PhenotypeApurva Jain, Mitesh J Borad, Robin Kate Kelley, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Ecancermedicalscience|April 23, 2021
National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemicZineb Benbrahim, Layth Mula-Hussain, Humaid O Al-Shamsi, et al.
Therapeutic Advances in Medical Oncology|September 4, 2024
Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trialsSara A Almansour, Mohammad A Y Alqudah, Ziad Abuhelwa, et al.
Cancer Treatment and Research Communications|February 27, 2022
Management of Early-Stage Resected Non-Small Cell Lung Cancer: Consensus Statement of the Lung cancer ConsortiumAhmed Allehebi, Khaled Al Kattan, Mashael Al Rujaib, et al.
Blood Advances|April 23, 2025
Statin use and survival in SLL/CLL treated with ibrutinib: Pooled analysis of four randomized controlled trialsAhmad Y Abuhelwa, Sara A Almansour, Jennifer R Brown, et al.
Journal of Gastrointestinal Oncology|August 27, 2016
Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experienceHumaid O Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, et al.
Journal of Gastrointestinal Oncology|January 13, 2017
Molecular spectrum of <i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i>, <i>PIK3CA</i>, <i>TP53</i>, and <i>APC</i> somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution patternHumaid O Al-Shamsi, Jeremy Jones, Yazan Fahmawi, et al.
European Journal of Haematology|March 14, 2025
Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple MyelomaAhmad Y Abuhelwa, Sara A Almansour, Ethan Basch, et al.
The Oncologist|June 15, 2020
Evolution of Cancer Care in Response to the COVID-19 PandemicEric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
The Oncologist|May 8, 2020
In ReplyEric A Coomes, Humaid O Al-Shamsi, Brandon M Meyers, et al.
JCO Precision Oncology|February 9, 2022
Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical PhenotypeApurva Jain, Mitesh J Borad, Robin Kate Kelley, et al.
Pageof 10